References
- Opie L H. Clinical use of calcium channel antagonist drugs, 2nd edn. Kluwer Academic Publ, Boston, Dordrecht, London 1990
- Kawai C, Konishi T, Matsuyama E, Okazaki H. Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine on the sinoatrial and atroventricular nodes; experimental and clinical studies. Circulation 1981; 63: 1035–42
- Mitchell L B., Jutzy K R., Lewis S J., Schroeder J S., Mason J W. Intracardiac electrophysiologic study of intravenous diltiazem and digoxin in patients. Am Heart J 1982; 103: 57–66
- Sugimoto T, Ishikawa T, Kaseno K, Nakase S. Electrophysiologic effects of diltiazem, a calcium antagonist, in patients with impaired sinus or atriventricular node function. Angiology 1980; 31: 700–9
- Schulman S P., Wiess J L., Becker L C., et al. The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Engl J Med 1990; 322: 1350–6
- Pollare T, Lithell H, Moürlin C, Präntare H, Hvarf-ner A, Ljunghall S. Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups. J Hypertens 1989; 7: 551–9
- Bronsky D, Dubin A, Kushner D S., Waldstein S S. Calcium and the electrocardiogram. Am J Cardiol 1961; 7: 833–9
- Bourassa M G., Cote P, Theroux J F., Genain C, Waters D D. Haemodynamics and coronary flow following diltiazem administration in anesthetized dogs and in humans. Chest 1980; 78: 224–30
- Nikkilä M T., Inkovaara J A., Heikkinen J T., Olsson S OR. Antihypertensive effect of diltiazem in a slow-release formulation for mild to moderate essential hypertension. Am J Cardiol 1989; 63: 1227–30
- van Wijk L M., vd Toren E, van Gelder I, Crijns H J., Ruegg P, Lie K L. Electrophysiological properties of isradipine (PN200–110) in humans. Cardiovasc Pharmacol 1989; 14: 392–495